BIG
ROIV icon

Brooklyn Investment Group’s Roivant Sciences ROIV Stock Holding History

Brooklyn Investment Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
50,312
+12,626
+34% +$324K 0.04% 409
2025
Q4 		$818K Buy
37,686
+22,018
+141% +$434K 0.04% 416
2025
Q3 		$178K Sell
15,668
-21
-0.1% -$260 0.02% 607
2025
Q2 		$177K Buy
15,689
+13,846
+751% +$150K 0.02% 670
2025
Q1 		$18.6K Buy
1,843
+1,839
+45,975% +$19.9K ﹤0.01% 1209
2024
Q4 		$48 Buy
+4
New +$47 ﹤0.01% 1836

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brooklyn Investment Group's ROIV Position: Q1 2026 in Review

Brooklyn Investment Group increased its Roivant Sciences (ROIV) stake by 34% in Q1 2026, buying an estimated $324K and bringing the position to 50,312 shares worth $1.39M. The position accounts for 0.04% of the portfolio, ranked #409.

Brooklyn Investment Group first reported a position in ROIV in Q4 2024 and has held it in 6 quarters since. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Brooklyn Investment Group held 50,312 shares of Roivant Sciences worth $1.39M as of Q1 2026.
  • Brooklyn Investment Group bought 12,626 Roivant Sciences shares in Q1 2026, an estimated $324K.
  • Roivant Sciences made up 0.04% of Brooklyn Investment Group's portfolio in Q1 2026, its #409 holding.
  • Brooklyn Investment Group first reported a position in Roivant Sciences in Q4 2024 and has held it in 6 quarters since.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.